Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ORIC Pharmaceuticals Inc shares valued at $73,298 were sold by Piscitelli Dominic on Dec 16 ’24. At $8.28 per share, Piscitelli Dominic sold 8,851 shares. The insider’s holdings dropped to 106,764 shares worth approximately $0.85 million following the completion of this transaction.
Also, Multani Pratik S sold 8,850 shares, netting a total of over 73,293 in proceeds. Following the sale of shares at $8.28 each, the insider now holds 46,765 shares.
Before that, Chacko Jacob had sold 24,660 shares from its account. In a trade valued at $204,214, the PRESIDENT AND CEO traded ORIC Pharmaceuticals Inc shares for $8.28 each. Upon closing the transaction, the insider’s holdings decreased to 24,660 shares, worth approximately $6.18 million.
As published in their initiating research note from Wells Fargo on October 31, 2024, ORIC Pharmaceuticals Inc [ORIC] has been an Overweight and the price target has been revised to $20. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of February 23, 2024, Cantor Fitzgerald has initiated its “an Overweight” rating for ORIC. Earlier on September 22, 2023, Wedbush initiated its rating. Their recommendation was “an Outperform” for ORIC stock.
Analyzing ORIC Stock Performance
During the last five days, there has been a drop of approximately -19.39%. Over the course of the year, ORIC Pharmaceuticals Inc shares have dropped approximately -1.61%. Shares of the company reached a 52-week high of $14.67 on 02/10/25 and a 52-week low of $7.48 on 02/18/25. A 50-day SMA is recorded $9.39, while a 200-day SMA reached $9.38. Nevertheless, trading volume fell to 1.88 million shares from 1.44 million shares the previous day.
Support And Resistance Levels for ORIC Pharmaceuticals Inc (ORIC)
According to the 24-hour chart, there is a support level at 7.56, which, if violated, would cause prices to drop to 7.17. In the upper region, resistance lies at 8.45. The next price resistance is at 8.95. RSI (Relative Strength Index) is 37.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.11, which suggests the price will decrease in the coming days. Percent R is at 93.60%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of ORIC Pharmaceuticals Inc (ORIC)?
On March 23, 2023, H.C. Wainwright assigned a price target of “a Buy” to the stock and upgraded coverage with a $16.
